ScholarWorks Collection: https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/409 2026-07-03T22:24:50Z 새로 승인받은 항생제 - Cefiderocol https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/217791 Title: 새로 승인받은 항생제 - Cefiderocol Authors: 김봉영 2026-06-20T00:00:00Z Comparison of the risk of acute anterior uveitis flare between adalimumab and subcutaneous infliximab in patients with radiographic axial spondyloarthritis and prior acute anterior uveitis: a randomized controlled trial https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/217651 Title: Comparison of the risk of acute anterior uveitis flare between adalimumab and subcutaneous infliximab in patients with radiographic axial spondyloarthritis and prior acute anterior uveitis: a randomized controlled trial Authors: 김태환 2026-06-05T00:00:00Z NSD1, H3K36me1/2 methyltransferase as a potential therapeutic target in th17 cell-mediated autoinflammatory disease https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/217652 Title: NSD1, H3K36me1/2 methyltransferase as a potential therapeutic target in th17 cell-mediated autoinflammatory disease Authors: 김태환 2026-06-05T00:00:00Z . Multi-ancestry GWAS of radiographic progression in axial spondyloarthritis https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/217653 Title: . Multi-ancestry GWAS of radiographic progression in axial spondyloarthritis Authors: 김태환 2026-06-05T00:00:00Z